Sunset Pharmaceuticals

1. Acquire

1.1. Phase 1 Successful, 30%, $60M

1.1.1. Phase II Successful for pancreatic ca, 25%, $170M

1.1.1.1. Phase III Successful for Pancreatic Ca, 40%, $300 M

1.1.1.1.1. Drug launched for pancreatic ca, $250M

1.1.1.1.2. Do not launch

1.1.1.2. Phase III Not Successful for Pancreatic Ca, 60%, $300M

1.1.2. Phase II Not Succesful, 75%, $170M

1.1.3. Phase II Successful for Liver Ca, 45%, $170 M

1.1.3.1. Phase III Successful for Liver Ca, 70% $350M

1.1.3.1.1. Drug launched for liver ca, $200M

1.1.3.1.2. Do not launch

1.1.3.2. Phase III Not Successful for Liver Ca, 30%, $350M

1.1.4. Phase II Not Successful for Liver Ca, 55%, $170M

1.2. Phase 1 Not Successful, 70%, $60M

2. Don't Acquire